TickerFacts.

Baird Medical Investment Holdings Ltd (BDMD): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$1.10M
Year ended 2025-12-31
+6.4%
3-year compound annual growth
$1.14M2022-12-31: $916.1K2023-12-31: $1.01M2024-12-31: $1.14M2025-12-31: $1.10M$1.10M
2022-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$1.10M-3.1%2026-07-27, From 2025-01-01
2024-12-31$1.14M+12.3%2026-07-27, From 2024-01-01
2023-12-31$1.01M+10.7%2026-07-27, From 2023-01-01
2022-12-31$916.1Kn/a2025-05-15, From 2022-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$1.10M-3.1%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$139.0K+0.7%
Nephros Inc (NEPH)2025-12-31$140.0K+3.7%
Sensus Healthcare, Inc. (SRTS)2025-12-31$400.0K+100.0%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$1.31M+125.3%
Premier Air Charter Holdings Inc. (PREM)2025-12-31$744.6K+236.5%
Allurion Technologies, Inc. (ALUR)2025-12-31$983.0K-1.4%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$327.0K+6.2%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$814.0K-16.9%

Compare BDMD, SNOA, NEPH, SRTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗